Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Head & Neck
|
January 18, 2014
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative
Mark L Urken, Mira Milas, Gregory W Randolph, et al.
The Lancet. Oncology
|
September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
Keith C Bible, Vera J Suman, Julian R Molina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 28, 2015
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma
Katayoon Kasaian, Ana-Maria Chindris, Sam M Wiseman, et al.
Rare Tumors
|
October 5, 2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma
Jaime I Davila, Jason S Starr, Steven Attia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
Keith C Bible, Vera J Suman, Michael E Menefee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Naiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
Keith C Bible, Vera J Suman, Julian R Molina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 3, 2010
Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target
Laura A Marlow, Jaclyn D'Innocenzi, Yilin Zhang, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 19, 2014
What is the gold standard for comprehensive interinstitutional communication of perioperative information for thyroid cancer patients? A comparison of existing electronic health records with the current American Thyroid Association recommendations
Laura L Dos Reis, R Michael Tuttle, Eran Alon, et al.
Expert Review of Anticancer Therapy
|
October 25, 2022
Evaluating new treatments for anaplastic thyroid cancer
Andrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Head & Neck
|
January 18, 2014
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative
Mark L Urken, Mira Milas, Gregory W Randolph, et al.
The Lancet. Oncology
|
September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
Keith C Bible, Vera J Suman, Julian R Molina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 28, 2015
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma
Katayoon Kasaian, Ana-Maria Chindris, Sam M Wiseman, et al.
Rare Tumors
|
October 5, 2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma
Jaime I Davila, Jason S Starr, Steven Attia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
Keith C Bible, Vera J Suman, Michael E Menefee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Naiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
Keith C Bible, Vera J Suman, Julian R Molina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 3, 2010
Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target
Laura A Marlow, Jaclyn D'Innocenzi, Yilin Zhang, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 19, 2014
What is the gold standard for comprehensive interinstitutional communication of perioperative information for thyroid cancer patients? A comparison of existing electronic health records with the current American Thyroid Association recommendations
Laura L Dos Reis, R Michael Tuttle, Eran Alon, et al.
Expert Review of Anticancer Therapy
|
October 25, 2022
Evaluating new treatments for anaplastic thyroid cancer
Andrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
Page
of 7